摘要:
Because of having an anti-arthritic effect, inhibiting bone fracture induced by arthritis and having a high safety, benzophenone derivatives represented by the following general formula or salts thereof are useful as remedies for arthritis with favorable dynamics in vivo: wherein R1 represents an optionally substituted heterocycle, substituted phenyl, etc. Z represents alkylene, etc. R2 represents optionally alkyl-blocked carboxyl, etc. R3 represents an optionally blocked hydroxy, etc. R4 represents an optionally substituted cycloalkyloxy, etc. and R5 represents hydrogen, etc. Moreover, these compounds have an AP-1 activity inhibitory effect, which makes them useful as preventives and remedies for diseases in which the overexpression of AP-1 participates.
摘要翻译:由下式表示的二苯甲酮衍生物:其中R 1表示例如可以具有取代基的杂环基或取代苯基的 Z表示例如亚烷基; R 2表示例如任选被烷基保护的羧基; R 3表示例如任选保护的羟基; R 4表示例如任选取代的环烷氧基; R 5表示例如氢原子或其盐具有抗关节炎活性,抑制由关节炎引起的骨破坏,提供高安全性和优异的药代动力学,因此可用作关节炎的治疗剂。 这些化合物对AP-1活性具有抑制作用,可用作涉及AP-1过度表达的疾病的预防或治疗剂。
摘要:
A compound represented by formula (I) (wherein all the symbols are as defined in the specification) or a salt thereof Since the compound represented by formula (I) or a salt thereof has a regulatory activity for peroxisome proliferator activated receptor, the compound represented by formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or therapeutic agent for diseases associating metabolic disorders ( e . g ., diabetes, adiposity, metabolic syndrome, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipidemia, atherosclerosis, hypertension, circulatory diseases, overeating, ischemic heart diseases, etc ., a HDL cholesterol-elevating agent, a LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diabetes or metabolic syndrome.
摘要:
Cytokine production inhibitors containing as the active ingredient aniline derivatives represented by the general formula (I) or salts thereof: (I) wherein A is CO or SO2; Cy is aryl or a heterocyclic group; R?1 and R2¿ are each independently halogeno, cyano, nitro, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted aryl, an optionally substituted heterocyclic group, optionally substituted amino, or B-Q; R?3 is M1-M2-R5; R4¿ is hydrogen or optionally substituted alkyl; x is an integer of 0 to 5; y is an integer of 0 to 4; and z is an integer of 0 to 1.
摘要翻译:本发明提供含有作为活性成分的式(I)的苯胺衍生物或其盐的细胞因子产生抑制剂:其中A是CO或SO 2; Cy是芳基或杂环基; R 1和R 2各自独立地为卤原子,氰基,硝基,可被取代的烷基,可被取代的烯基,炔基 可以被取代的环烷基,可被取代的环烯基,可被取代的芳基,可被取代的杂环基,可被取代的氨基或-BQ基; R 3是-M 1 -M 2 -R 5基团; R 4是氢原子或可被取代的烷基; x为0〜5的整数; y为0〜4的整数; z是0到1之间的整数。
摘要:
A heat sensitive recording material, comprising a) at least one colour forming compound, and b) at least one developer of formula (1), wherein R1 is unsubstituted or substituted phenyl, naphthyl or C1-C20 alkyl, X is a group of formula (i), (ii) or (iii), A is unsubstituted or substituted phenylene, naphthylene or C1-C12 alkylene, or is an unsubstituted or substituted heterocyclic group, B is a linking group of formula -O-SO2-, -SO2-O-, -NH-SO2-, -SO2-NH-, -S-SO2-, -O-CO-, -O-CO-NH-, -NH-CO-, -NH-CO-O-, -S-CO-NH-, -S-CS-NH-, -CO-NH-SO2-, -O-CO-NH-SO2-, -NH=CH-, -CO-NH-CO-, -S-, -CO-, -O-, -SO2-NH-CO-, -O-CO-O- and -O-PO-(OR2)2, and R2 is unsubstituted or substituted aryl or benzyl or C1-C20alkyl, with the proviso, that, if B is not a linking group of formula -O-SO2-, R2 is unsubstituted or substituted phenyl, naphthyl or C1-C8 alkyl and that, if B is -O-, R2 is not alkyl.
摘要:
The invention concerns benzenic sulphonamide derivatives corresponding to the general formula (I) wherein: the different symbols have different meanings, their optical isomers and the pharmaceutically acceptable salts of said derivatives, and their uses for making medicines as radiolabelled pharmacological tools of thromboxane A2 receptors.